최진우 (경희대학교 약학대학)님 | 한빛사연구자 > 한빛사

경희대학교 약학대학

최종업데이트 2024.04.01.

Therapeutic Potential of HSP90 Inhibitor 17-DMAG in Regulating METTL3 for Kidney Fibrosis Treatment
- J. Am. Soc. Nephrol., Jan 26 2026, | https://doi.org/10.1681/ASN.0000000975
- 2026-01
- 의약학
- 한빛사논문
Transferrin-binding domain inserted-adenovirus hexon engineering enables systemic immune evasion and intratumoral T-cell activation
- Theranostics, Published 2025-1-1, 15 (4) | https://doi.org/10.7150/thno.105163
- 2025-01
- 의약학
- 한빛사논문
Intravesical instillation-based mTOR-STAT3 dual targeting for bladder cancer treatment
- J. Exp. Clin. Cancer Res., Jun 18 2024, 43 (1) | https://doi.org/10.1186/s13046-024-03088-7
- 2024-06
- 의약학
- 한빛사논문
Transcriptome-based deep learning analysis identifies drug candidates targeting protein synthesis and autophagy for the treatment of muscle wasting disorder
- Exp. Mol. Med., 01 April 2024 | https://doi.org/10.1038/s12276-024-01189-z
- 2024-04
- 의약학
- 한빛사논문
Isolation and Genomic Analysis of Single Circulating Tumor Cell Using Human Telomerase Reverse Transcriptase and Desmoglein-2
- Small Methods, First published: 17 January 2022 | https://doi.org/10.1002/smtd.202100938
- 2022-01
- 의약학
- 한빛사논문

연구자 ID

저자논문